More than one-third of children with peanut allergy successfully built up their tolerance to peanut protein after treatment with an immunotherapy skin patch, a study with Australian participants has shown.

However, the results failed to meet a statistical element of the primary outcome set by the US Food and Drug Administration, leaving clinicians to decide for themselves if the peanut-patch treatment has promise.